First Time Loading...
A

ABL Bio Inc
KOSDAQ:298380

Watchlist Manager
ABL Bio Inc
KOSDAQ:298380
Watchlist
Price: 25 400 KRW -0.59%
Updated: May 22, 2024

Intrinsic Value

ABL Bio Inc's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

ABL Bio, Inc. engages in the development of therapeutic drugs for immuno-oncology and neurodegenerative diseases. [ Read More ]

The intrinsic value of one ABL Bio Inc stock under the Base Case scenario is 8 374.41 KRW. Compared to the current market price of 25 400 KRW, ABL Bio Inc is Overvalued by 67%.

Key Points:
Intrinsic Value
Base Case
8 374.41 KRW
Overvaluation 67%
Intrinsic Value
Price
A
Worst Case
Base Case
Best Case

Valuation Backtest
ABL Bio Inc

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling ABL Bio Inc stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
ABL Bio Inc

Provide an overview of the primary business activities
of ABL Bio Inc.

What unique competitive advantages
does ABL Bio Inc hold over its rivals?

What risks and challenges
does ABL Bio Inc face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for ABL Bio Inc.

Provide P/S
for ABL Bio Inc.

Provide P/E
for ABL Bio Inc.

Provide P/OCF
for ABL Bio Inc.

Provide P/FCFE
for ABL Bio Inc.

Provide P/B
for ABL Bio Inc.

Provide EV/S
for ABL Bio Inc.

Provide EV/GP
for ABL Bio Inc.

Provide EV/EBITDA
for ABL Bio Inc.

Provide EV/EBIT
for ABL Bio Inc.

Provide EV/OCF
for ABL Bio Inc.

Provide EV/FCFF
for ABL Bio Inc.

Provide EV/IC
for ABL Bio Inc.

Show me price targets
for ABL Bio Inc made by professional analysts.

What are the Revenue projections
for ABL Bio Inc?

How accurate were the past Revenue estimates
for ABL Bio Inc?

What are the Net Income projections
for ABL Bio Inc?

How accurate were the past Net Income estimates
for ABL Bio Inc?

What are the EPS projections
for ABL Bio Inc?

How accurate were the past EPS estimates
for ABL Bio Inc?

What are the EBIT projections
for ABL Bio Inc?

How accurate were the past EBIT estimates
for ABL Bio Inc?

Compare the revenue forecasts
for ABL Bio Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of ABL Bio Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of ABL Bio Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of ABL Bio Inc compared to its peers.

Compare the P/E ratios
of ABL Bio Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing ABL Bio Inc with its peers.

Analyze the financial leverage
of ABL Bio Inc compared to its main competitors.

Show all profitability ratios
for ABL Bio Inc.

Provide ROE
for ABL Bio Inc.

Provide ROA
for ABL Bio Inc.

Provide ROIC
for ABL Bio Inc.

Provide ROCE
for ABL Bio Inc.

Provide Gross Margin
for ABL Bio Inc.

Provide Operating Margin
for ABL Bio Inc.

Provide Net Margin
for ABL Bio Inc.

Provide FCF Margin
for ABL Bio Inc.

Show all solvency ratios
for ABL Bio Inc.

Provide D/E Ratio
for ABL Bio Inc.

Provide D/A Ratio
for ABL Bio Inc.

Provide Interest Coverage Ratio
for ABL Bio Inc.

Provide Altman Z-Score Ratio
for ABL Bio Inc.

Provide Quick Ratio
for ABL Bio Inc.

Provide Current Ratio
for ABL Bio Inc.

Provide Cash Ratio
for ABL Bio Inc.

What is the historical Revenue growth
over the last 5 years for ABL Bio Inc?

What is the historical Net Income growth
over the last 5 years for ABL Bio Inc?

What is the current Free Cash Flow
of ABL Bio Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for ABL Bio Inc.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
ABL Bio Inc

Current Assets 102.6B
Cash & Short-Term Investments 100.6B
Receivables 331.5m
Other Current Assets 1.6B
Non-Current Assets 100.3B
Long-Term Investments 89.8B
PP&E 6.4B
Intangibles 2.6B
Other Non-Current Assets 1.5B
Current Liabilities 103.7B
Accrued Liabilities 344.8m
Short-Term Debt 40B
Other Current Liabilities 63.4B
Non-Current Liabilities 3.3B
Long-Term Debt 409.9m
Other Non-Current Liabilities 2.9B
Efficiency

Earnings Waterfall
ABL Bio Inc

Revenue
104.8B KRW
Operating Expenses
-70.1B KRW
Operating Income
34.7B KRW
Other Expenses
1.4B KRW
Net Income
36.1B KRW

Free Cash Flow Analysis
ABL Bio Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
Fundamental Scores

Profitability Score
Profitability Due Diligence

ABL Bio Inc's profitability score is 34/100. The higher the profitability score, the more profitable the company is.

Exceptional ROE
Exceptional ROIC
Exceptional 1-Year Revenue Growth
ROE is Increasing
34/100
Profitability
Score

ABL Bio Inc's profitability score is 34/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

ABL Bio Inc's solvency score is 77/100. The higher the solvency score, the more solvent the company is.

77/100
Solvency
Score

ABL Bio Inc's solvency score is 77/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
ABL Bio Inc

Wall Street analysts forecast ABL Bio Inc stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ABL Bio Inc is 36 720 KRW with a low forecast of 35 350 KRW and a high forecast of 38 850 KRW.

Lowest
Price Target
35 350 KRW
39% Upside
Average
Price Target
36 720 KRW
45% Upside
Highest
Price Target
38 850 KRW
53% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Competitors Analysis
ABL Bio Inc

Shareholder Return

Price
ABL Bio Inc

1M 1M
+10%
6M 6M
+30%
1Y 1Y
+10%
3Y 3Y
+25%
5Y 5Y
+7%
10Y 10Y
+7%
Annual Price Range
25 400
52w Low
15 530
52w High
28 000
Price Metrics
Average Annual Return 1.12%
Standard Deviation of Annual Returns 29.93%
Max Drawdown -58%
Shares Statistics
Market Capitalization 1.2T KRW
Shares Outstanding 47 892 500
Percentage of Shares Shorted
N/A

Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

ABL Bio Inc

Country

Korea

Industry

Biotechnology

Market Cap

1.2T KRW

Dividend Yield

0%

Description

ABL Bio, Inc. engages in the development of therapeutic drugs for immuno-oncology and neurodegenerative diseases. The company is headquartered in Seongnam, Gyeonggi-Do. The company went IPO on 2018-12-19. The major products include anti-angiogenesis antibodies anti-tumor targeting antibodies, T cell engager bispecific antibodies (TCEs), dual immune cell targeting bispecific antibodies (DICs), novel immune cell targeting antibodies (NICs), brain disease dual antibodies, antibody-drug conjugates (ADCs) , among others.

Contact

GYEONGGI-DO
Seongnam
2F, 16, Daewangpangyo-ro 712beon-gil, Bundang-gu
+823180189800
http://www.ablbio.com/

IPO

2018-12-19

Employees

90

Officers

Founder, President & CEO
Dr. Sang Hoon Lee Ph.D.
Executive VP, MD & CFO
Mr. Jaecheon Lee M.B.A., MBA
Executive VP & COO
Mr. Jung Dae Kim M.B.A.
Executive VP, Chief Scientific Officer & Head of R&D
Dr. You Weon-Kyoo PH.D.
Executive VP & Chief of Discovery
Dr. Jaeho Jung Ph.D.
Executive VP, Chief Translational Research Officer & Head of Early Development
Dr. Jong Hwa Won Ph.D.
Show More
Head of Medical & Clinical Development
Dr. Eunkyung Kim M.D., Ph.D.
Show Less

See Also

Discover More
What is the Intrinsic Value of one ABL Bio Inc stock?

The intrinsic value of one ABL Bio Inc stock under the Base Case scenario is 8 374.41 KRW.

Is ABL Bio Inc stock undervalued or overvalued?

Compared to the current market price of 25 400 KRW, ABL Bio Inc is Overvalued by 67%.